Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses challenges facing genetic testing for patients with prostate cancer.
Christopher J. Kane, MD
Advertisement
Articles by Christopher J. Kane, MD
Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses the impact of genetic testing on patients with prostate cancer.
Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses high-penetrance genetic syndromes in patients with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Kane on High-Penetrance Genetic Syndromes in Prostate CancerPublished: March 8th 2017 | Updated:
Dr. Kane on Genetic Testing for Prostate CancerPublished: April 20th 2017 | Updated:
Dr. Kane on Challenges Facing Genetic Testing in Prostate CancerPublished: July 19th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5